Steroidogenic enzyme (None (commonly referred to as "steroidogenic enzymes" or by specific enzyme names such as CYP11A1, 3β-HSD, etc.))

Steroidogenic enzymes are a group of proteins responsible for catalyzing each step in the conversion of cholesterol into biologically active steroid hormones. These include sex steroids—such as estrogens, progestogens, and androgens—as well as corticosteroids like glucocorticoids and mineralocorticoids. The most prominent members are cytochrome P450 monooxygenases—including cholesterol side-chain cleavage enzyme (CYP11A1), aromatase (CYP19A1), various hydroxylases—and several classes of hydroxysteroid dehydrogenases. Their expression is tightly regulated by tissue type and hormonal signals; dysregulation can contribute directly to diseases ranging from endocrine tumors to metabolic syndromes. Pharmacological inhibitors targeting these enzymes are used clinically for conditions like Cushing’s syndrome or certain cancers but require careful management due to risks associated with systemic hormonal disruption[3][5][7].

Other names

Steroid biosynthetic enzymeEnzyme of steroidogenesisSteroid hormone biosynthesis enzyme

Drugs targeting these enzymes typically act via: - Competitive inhibition at the active site of cytochrome P450s or dehydrogenases to block conversion steps in hormone synthesis. For example: - Ketoconazole inhibits multiple cytochrome P450s involved in cortisol and androgen synthesis. - Metyrapone inhibits 11β-hydroxylase activity to reduce cortisol production.[4]